Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

ClinicalTrials.gov ID: NCT01077154

Public ClinicalTrials.gov record NCT01077154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women With Early-Stage Breast Cancer at High Risk of Recurrence (D-CARE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase 3 trial is studying the effect of denosumab to see if it can prevent disease recurrence in the bone or in any other part of the body, when it is given as adjuvant therapy for women with early-stage breast cancer, who are at high risk of disease recurrence.

Study identification

NCT ID
NCT01077154
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
4,509 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2010 (Actual)
Primary completion
Aug 31, 2017 (Actual)
Completion
Mar 26, 2018 (Actual)
Last update posted
Sep 28, 2021

2010 – 2018

United States locations

U.S. sites
93
U.S. states
35
U.S. cities
84
Facility City State ZIP Site status
Research Site Birmingham Alabama 35205 —
Research Site Tucson Arizona 85724 —
Research Site Jonesboro Arkansas 72401 —
Research Site Alhambra California 91801 —
Research Site Anaheim California 92801 —
Research Site Beverly Hills California 90211 —
Research Site Campbell California 95008 —
Research Site Fresno California 93720 —
Research Site Fullerton California 92835 —
Research Site La Verne California 91750 —
Research Site Lancaster California 93534 —
Research Site Long Beach California 90813 —
Research Site Los Angeles California 90024 —
Research Site Los Angeles California 90025 —
Research Site Los Angeles California 90095-1772 —
Research Site Northridge California 91328 —
Research Site Redondo Beach California 90277 —
Research Site Santa Barbara California 93105 —
Research Site Santa Maria California 93454 —
Research Site Torrance California 90502 —
Research Site Denver Colorado 80220 —
Research Site Grand Junction Colorado 81501 —
Research Site New Haven Connecticut 06510 —
Research Site Boynton Beach Florida 33435 —
Research Site Coral Springs Florida 33065 —
Research Site Fort Lauderdale Florida 33316 —
Research Site Hollywood Florida 33021 —
Research Site Jacksonville Florida 32256 —
Research Site Melbourne Florida 32901 —
Research Site Athens Georgia 30607 —
Research Site Niles Illinois 60714 —
Research Site Indianapolis Indiana 46260 —
Research Site Cedar Rapids Iowa 52402 —
Research Site Hutchinson Kansas 67502 —
Research Site Wichita Kansas 67214 —
Research Site Paducah Kentucky 42003 —
Research Site Annapolis Maryland 21401 —
Research Site Baltimore Maryland 21201 —
Research Site Bethesda Maryland 20817 —
Research Site Columbia Maryland 21044 —
Research Site Boston Massachusetts 02114 —
Research Site Danvers Massachusetts 01923 —
Research Site Ann Arbor Michigan 48109 —
Research Site Detroit Michigan 48201 —
Research Site Edina Minnesota 55435 —
Research Site Minneapolis Minnesota 55407 —
Research Site Saint Louis Park Minnesota 55426 —
Research Site Jackson Mississippi 39202 —
Research Site Jefferson City Missouri 65109 —
Research Site Lincoln Nebraska 68510 —
Research Site Henderson Nevada 89052 —
Research Site Lebanon New Hampshire 03756-0001 —
Research Site Denville New Jersey 07834 —
Research Site Hackensack New Jersey 07601 —
Research Site East Setauket New York 11733 —
Research Site New York New York 10003 —
Research Site New York New York 10029 —
Research Site New York New York 10032 —
Research Site Nyack New York 10960 —
Research Site Asheville North Carolina 28806 —
Research Site High Point North Carolina 27262 —
Research Site Cincinnati Ohio 45242 —
Research Site Columbus Ohio 43210 —
Research Site Tulsa Oklahoma 74136 —
Research Site Hershey Pennsylvania 17033 —
Research Site Pittsburgh Pennsylvania 15213 —
Research Site Pawtucket Rhode Island 02860 —
Research Site Charleston South Carolina 29414 —
Research Site Columbia South Carolina 29210 —
Research Site Hilton Head Island South Carolina 29926 —
Research Site Sioux Falls South Dakota 57105 —
Research Site Chattanooga Tennessee 37404 —
Research Site Germantown Tennessee 38138 —
Research Site Nashville Tennessee 37203 —
Research Site Abilene Texas 79606-5208 —
Research Site Corpus Christi Texas 78463 —
Research Site Dallas Texas 75230-2510 —
Research Site Dallas Texas 75246 —
Research Site Dallas Texas 75390 —
Research Site El Paso Texas 79902 —
Research Site Garland Texas 75042 —
Research Site Houston Texas 77024 —
Research Site Houston Texas 77030 —
Research Site Plano Texas 75075 —
Research Site San Antonio Texas 78217 —
Research Site San Antonio Texas 78229 —
Research Site Tyler Texas 75702 —
Research Site Richlands Virginia 24641 —
Research Site Richmond Virginia 23230 —
Research Site Roanoke Virginia 24014 —
Research Site Seattle Washington 98109-1023 —
Research Site Seattle Washington 98133 —
Research Site Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 366 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01077154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 28, 2021 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01077154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →